WallStreetZenWallStreetZen

NASDAQ: FATE
Fate Therapeutics Inc Stock Ownership - Who owns Fate Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Fate Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cindy TahlChief Legal and Compliance Officer2026-01-0910,589$1.07
$11.28kSell
Bahram ValamehrPresident and CEO2026-01-095,190$1.07
$5.56kSell
Cindy TahlChief Legal and Compliance Officer2025-08-049,037$1.06
$9.57kSell
Bahram ValamehrPresident and CEO2025-08-0414,466$1.06
$15.39kSell

1 of 1

FATE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FATE insiders and whales buy or sell their stock.

FATE Shareholders

What type of owners hold Fate Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC22.12%25,712,223$31.63MInsider
Redmile Group LLC11.07%12,872,946$15.83MInstitution
Blackrock Inc8.75%10,176,487$12.52MInstitution
Amir Nashat8.47%9,852,967$12.12MInsider
Polaris Venture Management Co V LLC8.47%9,841,933$12.11MInsider
Redco II Master Fund LP7.72%8,977,624$11.04MInsider
Vanguard Group Inc7.72%8,971,347$11.03MInstitution
Johnson Johnson2.91%3,379,064$4.16MInstitution
Ovp Venture Partners VII LP2.58%2,998,112$3.69MInsider
Acadian Asset Management LLC2.52%2,931,893$3.61MInstitution

1 of 3

FATE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FATE51.23%48.77%Net SellingNet Selling
SPRO36.48%62.44%Net SellingNet Selling
UNCY37.90%21.29%
ORMP27.33%56.95%
TLSA2.64%40.06%
View Top Biotech Stocks

Fate Therapeutics Stock Ownership FAQ

Who owns Fate Therapeutics?

Fate Therapeutics (NASDAQ: FATE) is owned by 61.95% institutional shareholders, 58.97% Fate Therapeutics insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Fate Therapeutics shareholder, owning 25.71M shares representing 22.12% of the company. Redmile Group LLC's Fate Therapeutics shares are currently valued at $30.08M.

If you're new to stock investing, here's how to buy Fate Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.